Leiomyosarcoma

LAST UPDATED: Aug 08, 2021

Introduction

A leiomyosarcoma is a rare, malignant tumour displaying smooth muscle differentiation. Leiomyosarcomas comprise approximately 7% of all soft tissue sarcomas. The vast majority of these lesions occur in the uterus and gastrointestinal tract, and are rare in the skin.

In the skin, lesions are divided into the two subcategories of dermal and subcutaneous leiomyosarcomas due not only to their difference in location, but also due to differences in their likely site of origin and prognosis. 

This chapter is set out as follows:   


Clinical findings

Dermal leiomyosarcomas

  • Are believed to derive from precursor cells associated with the arrector muscles of the hair, the smooth muscle surrounding sweat glands or the genital dartos muscle
  • The majority arise between 40 and 60 years of age, with a male predilection 
  • Clinical findings
    • Usually on the extremities, particularly on the hairbearing extensor surfaces and on the lower extremities
    • Ill-defined, solitary swellings / nodules, smaller than 2 cm
    • The overlying epidermis may exhibit a pink, purple, brown, or red discoloration; crusting; or ulceration
    • As many as 95% of patients report pain in association with the lesion, although some report itching, burning or bleeding
  • Management is surgical, a wide local excision is required as recurrence rates of 40% have been reported. Dermal lesions almost never metastasize

Subcutaneous leiomyosarcomas

  • Are presumably derived from precursors in the muscular walls of veins and arteries
  • The inferior vena cava and veins of the lower extremities are the most common sites
  • There is a predilection for males
  • Lesions are deep-seated, well-defined, nodular tumours or swellings, which expand rapidly and can ulcerate. The leg is the most common site
  • Management is surgical. Subcutaneous lesions can metastasize quickly and have a mortality rate of about 30%

Clinical Images

Please refer to notes on image rights at bottom of the page with regards to individual image ownership.


Management

  • Management is in Secondary / Tertiary care - any enlarging nodule of unknown diagnosis should be referred urgently (two-week wait)
  • Treatment is with wide local excision

Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.

Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.

Quick Links

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco